Biotechnology
Overview
The Biotechnology industry consists of companies engaged in the research and development of new drugs, medical devices and procedures. The industry includes the manufacturing and marketing of drugs as a result of direct research and development. The Biotechnology industry excludes: (drug manufacturers without research and development operations, classified in Pharmaceuticals - Generic and Specialty), (advanced medical equipment wholesalers, classified in Advanced Medical Equipment.)
Chemokine Therapeutics Corp. Closes $885,000 Offering
Chemokine Therapeutics Corp. announced that it has closed, via a non-brokered private placement, an offering of approximately 5,900,000 units at a price of $0.15 per unit for gross proceeds to the Company of approximately $885,000 (the Offering).
Haemacure Corporation Raises $7.8 Million
Haemacure Corporation announced that it has raised $7.8 million through the exercise of amended Series B warrants and broker warrants issued as part of the private placement concluded in January 2007.
Bio-Extraction Inc. Announces Private Placement
Bio-Extraction Inc. announced that it has priced a private placement of 10,000,000 common shares at $0.35 per share for gross proceeds of $3,500,000. Closing of the private placement is scheduled for June 25, 2008. The common shares will be subject to a four month statutory hold period. The net...
NorDiag ASA Announces Rights Issue
NorDiag ASA announced that the Company's General Meeting has resolved the proposed rights issue of up to 25,002,457 new shares. The subscription period is from June 26, 2008 to and including July 9, 2008. The shareholders as of June 18, 2008 will receive 0.6254 subscription rights per share. The...
Expansion & New Markets
- Millipore Corporation Unveils Expanded Drug Discovery Development Facility In St. Charles, Missouri
- Aresa A/S Establishes Two Operational Subsidiaries in the Balkans
- Arrowhead Research Corporation Forms New Subsidiary To Commercialize Energy Storage Devices
- Medicago Inc. to Evaluate Establishment of a Pandemic Vaccine Production Facility in France in Collaboration With Genopole d'Evry in Paris
- INBIONET Corp. Establishes Korea-based Subsidiary
- INBIONET Corp. Establishes Korea-based Subsidiary
- Lonza Group AG Creates Lonza Engineering as New Business Unit
- Solagran Limited Gets Approval To Construct New Plant In Tomsk Free Economic Zone
- IDT Australia Limited Announces Opening Of New Facility
- Geneart AG Founds Subsidiary in the West Coast of the US
Upcoming Events
- Nexavar may help breast cancer drugs work longer
- UPDATE 1-Luna, Hansen to settle lawsuit; shares soar
- UPDATE 2-Allergan CEO: Marginal impact from proposed 'Botax'
- UPDATE 1-GTx to cut 28 pct of jobs; sees $1.1 mln Q4 charge
- Sunesis Pharma shares up for 2nd day on data, partnership talks
- UPDATE 1-Sanofi breast cancer drug gets FDA fast-track nod
- UPDATE 3-Roche arthritis drug effective in late-stage study
- GSK Consumer to restart ops in India state on Sat-exec
- CVS Caremark in $1 bln Texas pension fund contract
- UPDATE 1-William Young to succeed Ross as Biogen chairman
- Advanced Medical Equipment -1.90%
- Medical Equipment / Supplies / Distribution -1.67%
- Pharmaceuticals - Generic / Specialty -0.83%
- Healthcare Facilities -0.73%
- Pharmaceuticals - Diversified -0.42%
- Biotechnology +0.05%
- Managed Health Care +4.59%
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
